An in vitro approach was used to measure the genotoxicity of creosote-contaminated soil before and after four bioremediation processes. water-soluble mutagens accounted for 40% of the total mutagenic activity and they were stable at room temperature. The mutagenic activity in the bioslurry and biopile samples was due to either the processes themselves or to the added sludge/manure amendments. The in vitro approach was effective in monitoring bioremediated soils for genotoxicity and will be useful in future laboratory and in situ studies.
and groundwater contaminated with creosote (1, (13) (14) (15) (16) (17) . There are many methods available to remediate a hazardous waste site soil (18) (19) (20) (21) (22) . The presumptive treatments for soils, sediments, and sludge contaminated with organics at wood treatment sites are bioremediation, thermal desorption, and incineration (19) .
Bioremediation is a cost-effective process to degrade wastes, and techniques are reviewed elsewhere (23) (24) (25) (26) . Bioremediation takes advantage of the ability of bacteria (27) (28) (29) (30) , fungi (31, 32) , and plants (33) to degrade many toxicants. Indigenous bacteria and fungi often utilize organic toxicants as sources of carbon and energy (34, 35) and can be augmented with nutrients in situ or isolated and propagated outside the laboratory for use with specific hazardous soils (22, 36, 37) . Biosurfactants increase the solubility of the toxicants, which releases them from soil particles so that bacteria and fungi can more easily metabolize them (38) (39) (40) , but increased water solubility can lead to water contamination.
This research investigated the genotoxicity of creosote-contaminated soil from a closed Superfund site, the Reilly Tar site (RTS) in St. Louis Park, Minnesota, before and after bioremediation in four laboratory-scale processes: bioslurry (BS), biopile (BP), compost (CMP), and land treatment (LT). Mutagenic activity was measured in two Salmonella assay techniques (41, 42) . Reproducibility of the mutagenicity assay and the extraction scheme was determined, and the bioavailability of the mutagens in the BP soil was investigated. Chemical fractionation and identification of signature mutagens in the RTS soils are presented in a companion paper (43) .
Materials and Methods

Chemicals
The dichloromethane (DCM) used for the extraction of organics from the RTS soils and as a solvent for the Spiral mutagenicity assay (42) was gas chromatography grade, and the dimethyl sulfoxide (DMSO) used as a solvent for the plate incorporation mutagenicity bioassay (41) was a spectrophotometric grade. Both Bioslu-ry. The BS mixture used UTS of less than 1/4-inch particle size. Treatment was performed in stirred (500 rpm) glass laboratory reactors (8-liter capacities) and air was bubbled to the bottom of the reactors. Ports were provided at the top of the reactor for periodic addition of nutrients, slurry, or air. The soil slurry was amended to keep the carbon:nitrogen:phosphorus ratio at 100:10:1, and an Organisation for Economic Co-operation and Development (OECD) nutrient mixture was added that contained trace minerals and vitamins (44) . The BS soil samples for the mutagenicity assays were a composite sample from three separate BS treatments. A 1% activated sludge from a municipal wastewater treatment facility was used for one of the treatments to increase the bacterial diversity. Detailed descriptions of the bioslurry treatments are available (45) . BS soil samples for mutagenicity assays were taken after 41 days of operation.
Biopile. The BP process used UTS screened to less than 1-inch particle size. The BP reactor was a rectangular polyethylene tank that contained 2 cubic yards of soil with two humidified air ports (0.5 liter/min, equal to one complete air change/24 hr). Cow manure was added to the reactor at 1%, and nutrients were added to keep a constant ratio of 100:10:1 for carbon: nitrogen:phosphorus. The reactor was sealed during the course of this study. The BP sample for the mutagenicity studies was taken at 20 weeks from the middle of the BP reactor, which contained 5% fungi by weight from oyster mushrooms (Pleurotus ostrates).
Compost. The CMP process used UTS screened to less than 1/2-inch particle size. The CMP reactors consisted of 55-gal stainless steel inner drums that were welded, sealed, and insulated within 95-gal outer drums that prevented heat loss during the composting process. Details for the CMP treatment are available (46) . The composters were placed on a conveyor belt every day and rolled for 30 min. Samples of CMP for mutagenicity testing were taken at 12 weeks of operation.
Land Treatment. The LT process used UTS screened to less than 1/2-inch particle size. The LT reactors are described in detail elsewhere (47, 48) . In brief, an LT reactor consisted of a stainless steel pan containing about 30 kg of dry soil (1.5 cubic feet of soil). Soil was placed in the pan to a depth of 8 inches, which was characteristic of field-scale LT. Four of these pans were suspended in a water bath and housed in a custom-built Plexiglas and steel glove box (47) . Air Testing. Dichloromethane (200 ml) was added to 100 g of each of the five soil types (UTS, BS, BP, CMP, and LT) taken at the end of each process. The UTS was used as the starting soil for each process and therefore was the control soil at time zero. The soil/DCM mixture was sonicated for 15 min; this procedure was performed three times. The DCM was siphoned from the extracted soil, combined, dried with sodium sulfate and filtered through a 0.45 Reproducibility Studies Table 3 contains the data for the reproducibility evaluation of both the bioassay and the extraction scheme. The mean variation in the bioassay for each BP extract over a 3-week period (horizontal columns in Table 3 ) was 13.3%. The mean variation in the extraction scheme for the three BP extracts over a 3-week period (vertical columns in Table 3 ) was 12.7%. These low variations confirmed our confidence in the mutagenic potencies and suggested that the mutagens in the BP extract were stable at room temperature for at least 3 weeks.
Bioavailability Study
The bioavailability of the mutagens in the UTS and the BP extracts was investigated by extracting these two soils with six different solvents and then testing these extracts in YG1041 with and without S9 addition. Samples were tested at five dose levels, and the 100 pg/plate data are (51) . Three separate BP soil samples (1, 2, and 3) were extracted on the same day. Assay parameters were as follows: Salmonella strain YG1041, 10 dose levels in the linear portion of the dose-response curve (10-100 pg in 10 pg intervals), three plates/dose, no S9 addition, plate incorporation assay; assays were conducted 1 week apart from each other. bSD /mean x 100%.
depicted graphically in Figure 1 (-S9) and Figure 2 (+S9). The dotted lines on the two graphs denote DMSO solvent control values (100 revertants). An unambiguous mutagenic response was considered to be 300 revertants or three times the solvent control. Figure 1 demonstrated that for the direct-acting conditions, the BP extract had considerably more mutagenic activity than the UTS, especially with the water extract, which accounted for approximately 40% of the total mutagenicity in the BP extract. The toluene and DCM extracts of the BP soil without S9 also demonstrated appreciable mutagenic activity (Figure 1 ). When tested with S9 (Figure 2 ), the mutagenicity in the water extract of the BP soil was equal to the mutagenicity seen with DCM extraction for the UTS method to determine mutagenic activity; the plate incorporation assay permitted the determination of mutagenic potencies that could be ranked; and the bioavailability study identified the solubility of the mutagens. Obviously, the test strains and solvents could be modified to account for varying environmental conditions surrounding different types of hazardous waste sites. Ranking mutagenic activity is important in environmental testing to identify the most mutagenic samples and to prioritize multiple samples from the same site for future testing. Bioavailability studies are important for Superfund sites with both marine and freshwater boundaries (e.g., a marsh or a river that flows into the sea) because mutagens in such a site may be more soluble in either fresh water or seawater. Bioavailability could change depending on the soil type, the specific environmental conditions at the site, and the chemistry of the toxicant. In addition, on-site bioremediation could metabolize the mutagens into more water-soluble chemicals, which then could more easily contaminate groundwater (Figures 1 and 2) .
Fractionation and chemical analysis of the RTS soils were conducted to identify signature mutagens and are more fully discussed in Brooks et al. (43) (Table 2 ). The protocol for the plate assay (10 dose levels in the linear portion of the dose-response curve, triplicate plates per dose) reduced variation in the Salmonella assay to 15% or less (Table 3) . When the CV remain below 25%, a doubling of mutagenic potency becomes significant (58) and accurate ranking of mutagenic activity can be accomplished (59, 60) . When other Salmonella testing protocols are used (i.e., five dose levels over several orders of magnitude for the test sample), toxicity or saturation of the S9 metabolic activation system can cause the variation in mutagenic potencies to exceed 100% (58) .
In this research, the ability to accurately measure and quantify mutagenic activity of the four bioremediation processes allowed their effectiveness to be determined (Table 2 ). Elevated mutagenic activity was detected in the BS and BP extracts that was not present in the UTS ( Table 2 ). The high direct-acting mutagenic activity in the BS extract was surprising because creosote had been mutagenic only with S9 addition (5) . One possible reason for this direct-acting mutagenic activity may be that the BS process contained activated sludge from a municipal wastewater treatment facility that had a high input from industrial sources. The sludge may have contained nitroarenes, which are direct-acting mutagens, are highly mutagenic (61) , and have been detected in sludge from wastewater treatment plants from an industrial area (62 diet. The BP sample also contained fungi in addition to bacteria, which may have changed the metabolism in the BP reactor. The CMP also contained cow manure but the corn cobs may have eliminated the relatively small amount of directacting mutagenic activity by absorption. The LT did not contain any added manure or fungi and had little mutagenic activity. All possible modifications to any one procedure were not investigated in this research. However, the four bioremediation procedures were calibrated by the engineers to perform in an optimal manner.
The reductions in PAH concentrations (48 to 74%) in this study (43) are in agreement with a 50% reduction in creosote (by weight) conducted by Chapman and co-workers (63) . The PAH reductions indicated that the four bioremediation processes were closely equivalent. When the mutagenicity data were evaluated along with the PAH data, CMP and LT processes were the most efficient and least toxic bioremediation procedures.
Reproducibility and Bioavailability Studies
The reproducibility and low variation of the extraction scheme and the bioassay results were excellent (Table 3) , which then allowed a meaningful comparative investigation into the bioavailability of the mutagens in the UTS and BP soil (Figures 1 and  2) . The bioavailability results (Figures 1  and 2 ) agreed with the mutagenicity results in Table 2 . Mutagenic activity was detected in the UTS with S9 and DCM; however, water was able to extract both direct-acting and indirect-acting mutagens from the BP soil. The fact that the BP process made the mutagens soluble in water may be significant for on-site bioremediation, where water-soluble mutagens could contaminate groundwater supplies. Neither the saltwater extraction nor the 50:50 mixture removed any mutagens from the BP sample. The addition of a salt will generally change the characteristics of a solvent, including water. Because oil spills and creosote waste sites may have solvent fronts moving away from the point source of the contamination that may contain contaminants, the toluene extract data in Figure 1 showed that such a solvent front could contain solubilized mutagenic components.
Bioremediation is a powerful tool that can be used to lessen the mutagenic and carcinogenic hazards present at Superfund sites. However, more research is needed on the techniques of bioremediation to increase its efficiency. The coupling of chemical and in vitro biologic analyses can play a key role in the evaluation and monitoring of bioremediation processes, as demonstrated by this research (43) .
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